Review of the policy on Foreign Direct Investment in pharmaceuticals sectorinsertion of a new paragraph 6.2.25 to 'Circular 2 of 2011-Consolidated FDI Policy' .
📋
Contents
Cases Cited
Referred In
Notifications
Circulars
Forms
Manuals
Acts
Rules & Regulations
Case Laws New
Ref Provisions New
Plus +
Source NTF
Summary
Similar
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Foreign direct investment in pharmaceuticals: greenfield allowed under automatic route; brownfield subject to government approval. Amendment to the consolidated FDI policy inserts paragraph 6.2.25: greenfield pharmaceutical projects are permitted FDI under the automatic route, while existing (brownfield) pharmaceutical companies are permitted FDI only under the government approval route; the change takes immediate effect and will be reviewed after six months.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Foreign direct investment in pharmaceuticals: greenfield allowed under automatic route; brownfield subject to government approval.
Amendment to the consolidated FDI policy inserts paragraph 6.2.25: greenfield pharmaceutical projects are permitted FDI under the automatic route, while existing (brownfield) pharmaceutical companies are permitted FDI only under the government approval route; the change takes immediate effect and will be reviewed after six months.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
